Leuven, Belgium, November 2, 2022 – LynxCare, the Belgian-US pioneer in big data for healthcare, announced it has appointed Alexander Rombaut as Chief Strategy Officer. Alexander will be leading the company’s internal operations, global strategy and execution of the company’s international expansion plans.

“Alexander brings a wealth of experience in managing high growth businesses," said Georges De Feu, Co-founder and CEO of LynxCare. “Alexander’s experience in helping companies grow from start to scale and his previous experience at Collibra, the leader in Data Intelligence and the first Belgian unicorn, as Head of Corporate Development & Strategy demonstrates he is the perfect fit to join LynxCare and help execute on our vision. As a core member of the Executive Team, Alexander is a key addition to our already amazing team, I’m delighted to welcome him to the LynxCare Team!”

“I’m extremely excited to join the LynxCare Team to help execute on the vision that Georges, Dries and the whole LynxCare team have been working towards since 2015. Data in healthcare can provide tremendous value to hospitals, clinical research, and most importantly patients. LynxCare is leading that effort to provide value across the whole healthcare ecosystem,” said Alexander Rombaut.

Alexander Rombaut has more than a decade of experience in strategic and financial leadership roles at high growth scale-ups. Most recently he served as Director of Finance at Okera, the data access management platform, in New York City. He previously worked as Head of Corporate Development & Strategy at Collibra, where he served in multiple roles for over five years. Before that, he was Corporate Finance and Investment Associate at Bongo Captial in Jakarta, Indonesia.

About LynxCare 

LynxCare is the Belgian-US scale-up leading Big Data in healthcare. With an AI-driven data platform, they enable hospitals to unlock previously unavailable insights for better patient care and scientific research. Founded in 2015 by Georges De Feu (pharmacist) and Dries Hens (physician), LynxCare today is a rapidly growing Belgian scale-up backed by a 20Mio EUR Series A from venture capitalist funds like MTIP (CH), Elaia (FR), BtoV (DE) and Heran partners (BE). LynxCare currently employs 50 people, including doctors, biomedical scientists, data specialists of which 15+ researchers (PhD). They work with leading hospitals in Europe and the United States and facilitate scientific research for Life Sciences companies such as AstraZeneca, Pfizer and Novartis within a strict ethical and legal framework.

Learn more: https://www.lynx.care/